Archives for May 10, 2010

← 2010

DSM: XD scale-up can cut drug production costs

By Gareth Macdonald

DSM Biologics says successful XD tech expansion paves way for smaller bioreactors that lowers cost of production facilities and, ultimately, of bio-drug manufacture.